These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11210355)

  • 1. [Laxigal effectiveness in constipation of various etiology].
    Parfenov AI; Poleva NI
    Klin Med (Mosk); 2000; 78(12):49-50. PubMed ID: 11210355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open-label, dose-ranging pilot study of 4 weeks of low-dose therapy with sodium phosphate tablets in chronically constipated adults.
    Medoff J; Katz S; Malik P; Pambianco D; Pruitt R; Poulos J; Rank J; Rose M
    Clin Ther; 2004 Sep; 26(9):1479-91. PubMed ID: 15531010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised, placebo-controlled, double-blind study to investigate the efficacy and safety of the acute use of sodium picosulphate in patients with chronic constipation.
    Wulkow R; Vix JM; Schuijt C; Peil H; Kamm MA; Jordan C
    Int J Clin Pract; 2007 Jun; 61(6):944-50. PubMed ID: 17504357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical experiences with picosulfate sodium, a laxative from the group of diphenylmethanes].
    Ritschel W
    Wien Med Wochenschr; 1974 May; 124(19):294-7. PubMed ID: 4829687
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment with bisacodyl, picosulfate and prokinetics. Physiopathology and diagnosis of constipation].
    Müller-Lissner S
    Pharm Unserer Zeit; 2008; 37(2):130-4. PubMed ID: 18293319
    [No Abstract]   [Full Text] [Related]  

  • 6. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
    Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L
    Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experiences with the use of picosulfate in the puerperium].
    Morandi G; Carbonari B; Michelotti PG
    Clin Ter; 1969 Nov; 51(3):257-65. PubMed ID: 5407320
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of polyethylene glycol plus electrolytes in the treatment of severe constipation and faecal impaction in adults.
    Chen CC; Su MY; Tung SY; Chang FY; Wong JM; Geraint M
    Curr Med Res Opin; 2005 Oct; 21(10):1595-602. PubMed ID: 16238899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessments of anorectal myectomy for short segment hypoganglionosis in childhood.
    Ryouichi T; Howard ER
    Hepatogastroenterology; 2007; 54(73):91-5. PubMed ID: 17419238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tegaserod for female patients suffering from IBS with mixed bowel habits or constipation: a randomized controlled trial.
    Chey WD; Paré P; Viegas A; Ligozio G; Shetzline MA
    Am J Gastroenterol; 2008 May; 103(5):1217-25. PubMed ID: 18477346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, multicenter comparison of polyethylene glycol laxative and tegaserod in treatment of patients with chronic constipation.
    Di Palma JA; Cleveland MV; McGowan J; Herrera JL
    Am J Gastroenterol; 2007 Sep; 102(9):1964-71. PubMed ID: 17573794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot study on the efficacy of Picolax given as a four-week course for the treatment of refractory constipation.
    Chan AO
    Hong Kong Med J; 2012 Oct; 18(5):388-94. PubMed ID: 23018066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug eruption due to sodium picosulfate.
    Ishikawa A; Sugiura K; Sato A; Muro Y; Akiyama M
    Eur J Dermatol; 2012; 22(3):410-1. PubMed ID: 22407128
    [No Abstract]   [Full Text] [Related]  

  • 14. [Duphalac (lactulose) in the treatment of chronic constipation in children].
    Romańczuk W; Korczowski R
    Wiad Lek; 1995; 48(1-12):96-9. PubMed ID: 9638215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyethylene glycol solution in subgroups of chronic constipation patients: experience in obstructed defaecation.
    Bazzocchi G
    Ital J Gastroenterol Hepatol; 1999 Nov; 31 Suppl 3():S257-9. PubMed ID: 10726232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of irritable bowel syndrome. A case control experience.
    Astegiano M; Pellicano R; Terzi E; Simondi D; Rizzetto M
    Minerva Gastroenterol Dietol; 2006 Dec; 52(4):359-63. PubMed ID: 17108865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of abdominal bloating to distention in irritable bowel syndrome and effect of bowel habit.
    Houghton LA; Lea R; Agrawal A; Reilly B; Whorwell PJ
    Gastroenterology; 2006 Oct; 131(4):1003-10. PubMed ID: 17030170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome.
    Atkinson W; Lockhart S; Whorwell PJ; Keevil B; Houghton LA
    Gastroenterology; 2006 Jan; 130(1):34-43. PubMed ID: 16401466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constipation, laxative use and risk of colorectal cancer: The Miyagi Cohort Study.
    Watanabe T; Nakaya N; Kurashima K; Kuriyama S; Tsubono Y; Tsuji I
    Eur J Cancer; 2004 Sep; 40(14):2109-15. PubMed ID: 15341986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation--a 12-week, randomized, double-blind, placebo-controlled study.
    Quigley EM; Vandeplassche L; Kerstens R; Ausma J
    Aliment Pharmacol Ther; 2009 Feb; 29(3):315-28. PubMed ID: 19035970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.